| Canada | Canadian Urological Association (CUA) | English
| > 2015 – Canadian guideline for the management of small renal masses
> 2014 – Surgical management of renal cell carcinoma Canadian Kidney Cancer Forum Consensus
> 2017 – Management of advanced kidney cancer: Canadian Kidney Cancer Forum (CKCF) consensus update
> 2017 – CUA guideline on the management of cystic renal lesions
> 2016 – Structured assessment and followup for patients with hereditary kidney tumour syndromes
> 2018 – Canadian guideline on genetic screening for hereditary renal cell cancers
> 2018 – Canadian Urological Association guideline for followup of patients after treatment of non-metastatic renal cell carcinoma |
| Europe | European Association of Urology (EAU) | English
čeština
Português
Pусский язык
српски | > 2019 – EAU Guidelines on Renal Cell Carcinoma
> 2018 – EAU Guidelines on Renal Cell Carcinoma – Russian (Клинические рекомендации по почечно-клеточному раку), Russian Society of Oncourology
> 2011 – Renal Cell Carcinoma pocket – Serbian, Serbian Association of Urology
> 2010 – Urologické Listy condensed EAU Guidelines on Renal Cell Carcinoma – Czech (Pro léčbu karcinomu z renálních buněk)
> 2009 – Renal Cell Carcinoma pocket – Portuguese, Portuguese Association of Urology
|
| Europe | European Society for Medical Oncology (ESMO) | English | > 2020 – eUpdate – Renal Cell Carcinoma Treatment Recommendations
> 2019 – Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up |
| Germany | Deutsche Gesellschaft für Urologie
(DGU), Deutsche Gesellschaft für Hämatologie und
Onkologie (DGHO) im Rahmen des Leitlinienprogramms Onkologie | Deutsch | > 2017 – S3-Leitlinie Diagnostik, Therapie und Nachsorge des Nierenzellkarzinoms |
| Mexico | Mexico Oncogui Renal | Español | > 2016 – Diagnóstico y tratamiento del cáncer renal |
| Netherlands | Nederlandse Vereniging voor Urologie | Dutch | > 2018 – Behandelpad nierkanker |
| United Kingdom | UK National Institute for Health and Care Excellence (NICE) | English | The UK National Institute for Health and Care Excellence issues Guidance for treatment, especially focusing on when and how certain drugs might be used in treatment. See the index at:
> UK National Institute for Health and Care Excellence (NICE) – Kidney cancer |
| United Kingdom | UK Royal College of Radiologists (RCR) | English | > 2018 – Recommendations for cross-sectional imaging in cancer management, Second edition |
| United States | American Society of Clinical Oncology (ASCO) | English | > 2017 – Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline |
| United States | American Urological Association (AUA) | English | > 2017 – Renal Mass and Localized Renal Cancer
> 2013 – Ablation of Renal Masses |
| United States | National Cancer Institute (NIH) | English | > 2019 – Renal Cell Cancer Treatment (PDQ®)–Patient Version |
| United States | National Comprehensive Cancer Network® (NCCN®) | English
Chinese 中文
čeština
Deutsch
Español | > 2020 – Kidney cancer guidelines for patients English
> 2020 – Updated kidney cancer guidelines for physicians English
> 2015 – NCCN 患者指南 – 肾癌
> 2017 – Rakovina ledvin
> 2015 – NCCN – Guidelines for patients – Nierenkrebs
> 2017 – NCCN – Guidelines for patients – Cáncer de riñón
(Links provided with permission from NCCN®) |
| United States | VHL Alliance | English | > 2020 – Active surveillance guidelines 2020 |
